Nucleic acid delivery using modified chitosans

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) C12N 15/88 (2006.01)

Patent

CA 2751268

The present invention is directed to the delivery of nucleic acids in a non- viral vector to cells by positively charged chitosan deriva-tives, including but not limited to chi-tosan-arginine, chitosan-lysine and chitosan-histidine.

La présente invention porte sur l'administration d'acides nucléiques dans un vecteur non viral à des cellules par dérivés de chitosane chargées positivement, comprenant mais sans s'y limiter, la chitosane-arginine, la chitosane-lysine et la chitosane-histidine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nucleic acid delivery using modified chitosans does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid delivery using modified chitosans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid delivery using modified chitosans will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1707488

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.